MetaVia Inc. (NASDAQ:MTVA) IPO
IPO
Went public as Gemphire Therapeutics Inc. Priced at US$10.00 a share on Aug 4, 2016.
- Price
- US$10.00 a share
- Shares offered
- 3,000,000 shares of common stock
- Offering size
- US$30 million
- Underwriters' option
- Up to 450,000 more shares
- Listing
- GEMP on the Nasdaq Global Market
- Underwriters
- Jefferies, RBC Capital Markets, Canaccord Genuity, Laidlaw & Company (UK) Ltd., LifeSci Capital · In the order on the cover
- Shares delivered
- On or about Aug 10, 2016
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 11, 2015 |
| Filed publicly | Apr 18, 2016 |
| Amended twice | Newest Aug 4, 2016 |
| Shares registered with an exchange | Jun 20, 2016 |
| Declared effective by the SEC | Aug 4, 2016 |
| Final prospectus, with the price | Aug 8, 2016 |
Filings
From the cover of the final prospectus (424B4) filed Aug 8, 2016